InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Chen Yinlin Jack. Officer active across 1 company, notably Allogene Therapeutics, Inc.. In total, 1 reports have been published. Activity tracked since 10 August 2023. The latest transaction was filed on 10 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration